The primary goals of the Gynecologic Oncology Fellowship Program at Duke University Medical Center are to prepare trainees to deliver the best possible clinical care in the areas of diagnosis, treatment and prevention of gynecologic malignancies, and to provide a platform for trainees who aspire to careers in academics and research.

History of the Program

The Duke Gynecologic Oncology Fellowship was established in the early 1970s when formal programs were first created by the American Board of Obstetrics and Gynecology. The Division of Gynecologic Oncology and the fellowship program initially were founded and led by William T. Creasman, M.D. He played a pivotal role in the early endometrial cancer surgical staging studies performed by the GOG. In 1979, a year of laboratory research was incorporated into the Duke Gynecologic Oncology fellowship, and the first year research fellow does not have clinical responsibilities. Daniel L. Clarke-Pearson, M.D., became the Director of the Division of Gynecologic Oncology and the fellowship in 1986. He is a widely recognized researcher in the area of venous thrombosis. Under Dr. Clarke-Pearson’s leadership the faculty increased from two to five full-time gynecologic oncologists.

Our Director, Dr. Berchuck 

Andrew Berchuck, M.D. was appointed Director of the Duke Division of Gynecologic Oncology and of the fellowship program in 2006. Dr. Berchuck has been a member of the division since finishing training at Memorial Sloan-Kettering Cancer Center in 1987. He is a physician-scientist who has significant involvement in ovarian cancer molecular biology research while also caring for women with gynecologic cancers on a daily basis. In addition, Dr. Berchuck is involved in a wide range of national activities, including serving as 2007 President of the Society of Gynecologic Oncologists and as head of the scientific advisory committee of the Ovarian Cancer Research Fund.